CARVEFORD 6.25

Description

Carveford 6.25 Tablet contains carvedilol, a non-selective beta-blocker and alpha-1 blocker used for heart failure, hypertension, and heart protection after myocardial infarction.

Uses / Indications
Chronic Heart Failure: Commonly used in guideline-directed therapy; improves survival and reduces symptoms in patients with heart failure with reduced ejection fraction.

Hypertension: Reduces blood pressure and helps prevent stroke, heart attack, and kidney damage.

Left Ventricular Dysfunction after Myocardial Infarction: Protects and helps repair the heart after heart attack, especially when ejection fraction is reduced.

Other uses: Sometimes as adjunct for angina or arrhythmias, or to help with portal hypertension in liver disease.

Dosage & Administration
Heart failure: Typical titration: Start at 3.125 mg twice daily, then after 2 weeks (if tolerated) increase to 6.25 mg twice daily.

Hypertension/Myocardial infarction: 6.25 mg twice daily may be used as the initial or first titration dose.

Further increases can be made every 2 weeks if tolerated, up to 25 mg twice daily (maximum dose varies by clinical scenario and weight).

Tablets should be swallowed whole, best taken with food to minimize dizziness and low blood pressure.

How it Works / Key Benefits
Blocks β₁, β₂, and α₁ adrenergic receptors, slowing the heart, decreasing cardiac workload, and relaxing blood vessels.

Reduces symptoms of heart failure, lowers blood pressure, and prevents further cardiac events in post-MI patients.

Safety & Side Effects
Common: Dizziness, slow heartbeat (bradycardia), tiredness, low blood pressure, diarrhea, weight gain, weakness.

Serious (rare): Worsening heart failure, AV block, severe bradycardia, bronchospasm (not for asthmatics), severe liver impairment.

Do not stop carvedilol suddenly—taper on discontinuing. Dosing should always be increased or decreased only as per physician advice.

Note:
Carveford 6.25 is most often used as a step in the titration schedule towards the maintenance dose for heart failure or hypertension. Regular monitoring of blood pressure, heart rate, and symptoms is essential during treatment.